2023 Women's Imaging Preview

Road to RSNA 2023: Women's Imaging Preview
By Amerigo Allegretto
At RSNA 2023, a large variety of methods and modalities will be showcased for breast cancer screening, diagnosis, and treatment.
November 10, 2023
Road To Rsna
DWI-MRI improves treatment response prediction for cervical cancer
By Amerigo Allegretto
In this presentation, researchers will demonstrate how diffusion-weighted imaging MRI (DWI-MRI) may enhance chemoradiotherapy response prediction of early treatment timepoints for cervical cancer.
November 9, 2023
AI shows success in classifying interval breast cancers
By Amerigo Allegretto
Attendees will learn about how AI can classify interval breast cancers as minimal signs and reading-error misses in this session.
November 9, 2023
Deep-learning model identifies women with high breast cancer risk
By Amerigo Allegretto
In this scientific session, researchers will describe how a deep learning image-based risk model can identify women in their 40s who have a higher five-year future breast cancer risk.
November 9, 2023
AI can enable lower breast MRI contrast dose
By Erik L. Ridley
A deep learning-based technique could pave the way for lower doses of gadolinium-based contrast agents (GBCAs) in breast MRI, according to this presentation.
November 9, 2023
Malignancy rates on breast biopsy vary by modality
By Amerigo Allegretto
Malignancy rates for findings undergoing image-guided breast biopsy vary by the method of detection, according to research to be presented in this session.
November 9, 2023
AI can assess breast arterial calcifications on screening mammo
By Erik L. Ridley
In this talk, researchers will provide results from a multicenter study evaluating the use of AI software for assessing breast arterial calcifications.
November 9, 2023
In AI for breast cancer screening, three modalities are better than one
By Amerigo Allegretto
In this talk, researchers will reveal data showing that multimodal AI can yield better results than single-modality AI software in women screened with both mammography and ultrasound.
November 9, 2023
PET/CT upstages locally advanced breast cancer
By Amerigo Allegretto
Here, Canadian research will highlight how PET/CT upstages locally advanced breast cancer to stage IV more often than conventional imaging.
November 9, 2023
Molecular breast imaging and DBT: Better together
By Amerigo Allegretto
Molecular breast imaging shows its promise as a supplemental tool to further improve digital breast tomosynthesis (DBT), according to this scientific presentation.
November 9, 2023
Breast density impacts interval cancer rates
By Amerigo Allegretto
Here, a presentation will show how breast density impacts both interval cancer rates and overall cancer rates, which could further inform treatment and management strategies.
November 9, 2023
CEM can be used with low contrast dosage
By Amerigo Allegretto
In this session, research will demonstrate how low-dose contrast enhanced mammography (CEM) can be used without fear of sacrificing on diagnostic performance.
November 9, 2023
Page 1 of 2
Next Page